Business Wire
BusinessAmazon drops Alexa+ monthly fee for Fire TV users, stepping up competition in subscription AI assistantsThe Apex TimesBusinessWalmart adds more perks to Walmart+ as it leans harder into subscription rivalry with AmazonThe Apex TimesBusinessMcDonald’s stock-watchers look to its new beverage push as a potential catalystThe Apex TimesBusinessPfizer shares rise after peers’ mRNA cancer-trial readouts lift sentimentThe Apex TimesBusinessSOXL’s triple leverage magnifies Nvidia moves, and one $10,000 example is drawing attentionThe Apex TimesBusinessStock-Split Watch Turns to Lockheed Martin, but No Clear Trigger AppearsThe Apex TimesBusinessAMD and Intel slide after Google and Marvell outline custom AI-chip partnershipThe Apex TimesBusinessAmazon reframes its AWS and AI momentum, and outlines a major shift in capital spending expectationsThe Apex TimesBusinessYahoo Finance poses a long-horizon test: $1,000 in 2015 across NVIDIA, Apple and BitcoinThe Apex TimesBusinessBerkshire’s buyback pace accelerates under Greg Abel, according to a new filing cited by market reportsThe Apex TimesBusinessJPMorgan Chase shares fall even as broader markets rise, ending near $357The Apex TimesBusinessModerna and Merck lift big-biopharma sentiment as Treasury yields ease; S&P 500 and Nasdaq edge higherThe Apex TimesBusinessAmazon drops Alexa+ monthly fee for Fire TV users, stepping up competition in subscription AI assistantsThe Apex TimesBusinessWalmart adds more perks to Walmart+ as it leans harder into subscription rivalry with AmazonThe Apex TimesBusinessMcDonald’s stock-watchers look to its new beverage push as a potential catalystThe Apex TimesBusinessPfizer shares rise after peers’ mRNA cancer-trial readouts lift sentimentThe Apex TimesBusinessSOXL’s triple leverage magnifies Nvidia moves, and one $10,000 example is drawing attentionThe Apex TimesBusinessStock-Split Watch Turns to Lockheed Martin, but No Clear Trigger AppearsThe Apex TimesBusinessAMD and Intel slide after Google and Marvell outline custom AI-chip partnershipThe Apex TimesBusinessAmazon reframes its AWS and AI momentum, and outlines a major shift in capital spending expectationsThe Apex TimesBusinessYahoo Finance poses a long-horizon test: $1,000 in 2015 across NVIDIA, Apple and BitcoinThe Apex TimesBusinessBerkshire’s buyback pace accelerates under Greg Abel, according to a new filing cited by market reportsThe Apex TimesBusinessJPMorgan Chase shares fall even as broader markets rise, ending near $357The Apex TimesBusinessModerna and Merck lift big-biopharma sentiment as Treasury yields ease; S&P 500 and Nasdaq edge higherThe Apex TimesBusinessAmazon drops Alexa+ monthly fee for Fire TV users, stepping up competition in subscription AI assistantsThe Apex TimesBusinessWalmart adds more perks to Walmart+ as it leans harder into subscription rivalry with AmazonThe Apex TimesBusinessMcDonald’s stock-watchers look to its new beverage push as a potential catalystThe Apex TimesBusinessPfizer shares rise after peers’ mRNA cancer-trial readouts lift sentimentThe Apex TimesBusinessSOXL’s triple leverage magnifies Nvidia moves, and one $10,000 example is drawing attentionThe Apex TimesBusinessStock-Split Watch Turns to Lockheed Martin, but No Clear Trigger AppearsThe Apex TimesBusinessAMD and Intel slide after Google and Marvell outline custom AI-chip partnershipThe Apex TimesBusinessAmazon reframes its AWS and AI momentum, and outlines a major shift in capital spending expectationsThe Apex TimesBusinessYahoo Finance poses a long-horizon test: $1,000 in 2015 across NVIDIA, Apple and BitcoinThe Apex TimesBusinessBerkshire’s buyback pace accelerates under Greg Abel, according to a new filing cited by market reportsThe Apex TimesBusinessJPMorgan Chase shares fall even as broader markets rise, ending near $357The Apex TimesBusinessModerna and Merck lift big-biopharma sentiment as Treasury yields ease; S&P 500 and Nasdaq edge higherThe Apex TimesBusinessAmazon drops Alexa+ monthly fee for Fire TV users, stepping up competition in subscription AI assistantsThe Apex TimesBusinessWalmart adds more perks to Walmart+ as it leans harder into subscription rivalry with AmazonThe Apex TimesBusinessMcDonald’s stock-watchers look to its new beverage push as a potential catalystThe Apex TimesBusinessPfizer shares rise after peers’ mRNA cancer-trial readouts lift sentimentThe Apex TimesBusinessSOXL’s triple leverage magnifies Nvidia moves, and one $10,000 example is drawing attentionThe Apex TimesBusinessStock-Split Watch Turns to Lockheed Martin, but No Clear Trigger AppearsThe Apex TimesBusinessAMD and Intel slide after Google and Marvell outline custom AI-chip partnershipThe Apex TimesBusinessAmazon reframes its AWS and AI momentum, and outlines a major shift in capital spending expectationsThe Apex TimesBusinessYahoo Finance poses a long-horizon test: $1,000 in 2015 across NVIDIA, Apple and BitcoinThe Apex TimesBusinessBerkshire’s buyback pace accelerates under Greg Abel, according to a new filing cited by market reportsThe Apex TimesBusinessJPMorgan Chase shares fall even as broader markets rise, ending near $357The Apex TimesBusinessModerna and Merck lift big-biopharma sentiment as Treasury yields ease; S&P 500 and Nasdaq edge higherThe Apex Times
Back to front
Bank of America turns bullish on Medtronic ahead of earnings, citing a second catalyst building
The Apex Times

THE APEX TIMES

Business/The Apex Times/Aug 19, 6:42 PM EDT

Bank of America turns bullish on Medtronic ahead of earnings, citing a second catalyst building

A market note tied Bank of America’s outlook to Medtronic’s still-strong near-term momentum, while pointing to another potential driver developing into a later date.

2 min readEditor-approved Apex article

Bank of America is projecting a constructive setup for Medtronic as the medical-device company moves toward its next earnings period, according to a market report carried by Yahoo Finance and TheStreet.

The note frames Medtronic as a “77-year-old” healthcare stock, highlighting that while investors will focus on near-term performance into earnings, the bank also sees signs that an additional catalyst could build after the immediate quarter.

In the report’s characterization, one of Medtronic’s growth engines remains “running hot,” suggesting that a specific area of the business is still performing strongly enough to matter for the coming results.

The same market commentary also implies that another potential driver is emerging, though it does not lay out detailed timing, financial impact, or the exact milestones that would determine whether that catalyst materializes.

As a practical matter, this kind of “two-stage” view is common in healthcare-equipment coverage: analysts often anchor the immediate quarter on what is already showing traction, then look for indicators that can broaden the story for later quarters.

Medtronic, the healthcare company at the center of the call, operates across medical technologies used by hospitals and clinicians. For investors, the key question is usually how much of near-term demand is durable and whether any newer initiatives can translate into measurable results over time.

The market note, however, does not provide the level of detail typically needed to fully assess the call, such as specific growth drivers by product line, updated estimates, or an explicit price target within the information provided here.

Going forward, traders and long-term shareholders will likely watch what Medtronic reports in its next earnings release, particularly any commentary that confirms the reported strength in the near-term growth engine and any references to what management expects next for the additional catalyst bank analysts are pointing to.

Why It Matters

  • An analyst bullish shift ahead of earnings can influence positioning, especially when the view is anchored to both immediate momentum and a later catalyst.
  • Healthcare-device names often move on the specifics of product-line performance and management commentary, so what Medtronic says on its growth drivers may determine whether the thesis holds.
  • Without disclosed estimates or targets in the market report details provided here, investors may need to rely on the company’s earnings disclosures to judge the strength of the “near-term” and “later catalyst” framing.

Sources

Key Facts

  • Bank of America expressed a bullish view on Medtronic in a market report published via Yahoo Finance and TheStreet.
  • The report ties the outlook to an earnings approach, with one growth engine described as still performing strongly into the near-term period.
  • It also points to another potential catalyst “building,” suggesting a later development beyond the immediate quarter.
  • The market note does not disclose detailed numbers, such as a revised forecast range or quantified expectations, in the information provided here.
  • Medtronic is identified in the coverage as the healthcare stock that is the subject of the bank’s call.

Finance Related